Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Interview: AstraZeneca’s Pangalos on Landmark DAPA-HF Resultsv

AstraZeneca’s head of R&D spoke to Scrip about the outstanding results for dapagliflozin in heart failure regardless of diabetes status.

Topic company-analysis diabetes

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Biocon’s Malaysia Insulin Facility Hit With 12 FDA Observations

The US FDA has slapped Biocon with a dozen observations over three units at its insulin manufacturing facility in Malaysia, but the Indian biotech firm says the problems can be remedied quickly and that US launch plans are on track for its insulin product glargine challenging French drug-maker Sanofi’s multi-billion-dollar Lantus.

Topic fda diabetes biopharmaceutical

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Hanmi Faces Another Licensee U-Turn, This Time Janssen On Obesity/Diabetes Drug

Janssen has returned the rights to an obesity/diabetes drug to originator Hanmi, after Phase II studies failed to achieve glycemic control targets and reflecting development difficulties in the sector. This is the fourth time for the Korean firm to face a U-turn of licensed out compounds. 

Topic diabetes obesity

Medtech Insight: 世界の医療機器・医療技術の最新情報

UK Plan To Speed Access To ‘Cutting-Edge’ Products

Changes are being made to the UK’s Accelerated Access Collaborative to help streamline access to ground-breaking medicines and diagnostic tools in areas like dementia, diabetes and cancer.

Topic business-strategies cancer diabetes

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Insulin Prices: House Hearing Displays Bipartisan Commitment To Rapid Reform

Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.

Topic Diabetes

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Pharma Diabetes Market Intelligence

These reports includes 20-year forecasts of prevalent type 1 and type 2 diabetes cases segmented by age and gender, and drug-treated diabetes, segmented by treatment type.

Topic diabetes

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

ADA Meeting's Around The Corner: Five Things To Watch For

Among other debates at the American Diabetes Association annual meeting, clinicians will discuss the future of cardiovascular outcomes studies for diabetes drugs – whether they should maintain course or are due for an overhaul.

Topic diabetes

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Future market dynamics in type 2 diabetes

With the type two diabetes market undergoing unprecedented changes its important to know how this will shape the future dynamics of this competitive market. With our coverage you're able to analyse every aspect of this market.

Topic Diabetes